These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 10398973

  • 21. Phase III trial of oral magnetic particles in MRI of abdomen and pelvis.
    MacVicar D, Jacobsen TF, Guy R, Husband JE.
    Clin Radiol; 1993 Mar; 47(3):183-8. PubMed ID: 8472481
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oral magnetic particles as a contrast agent for MR imaging of the abdomen. A phase III clinical trial.
    Vlahos L, Gouliamos A, Kalovidouris A, Athanasopoulou A, Kotoulas G, Lygidakis N, Liaou A, Matsaidonis D, Papavasiliou C.
    Hepatogastroenterology; 1994 Feb; 41(1):82-5. PubMed ID: 8175124
    [Abstract] [Full Text] [Related]

  • 24. Oral magnetic particles (ferristene) as a contrast medium in abdominal magnetic resonance imaging.
    Jacobsen TF, Laniado M, Van Beers BE, Dupas B, Boudghène FP, Rummeny E, Falke TH, Rinck PA, MacVicar D, Lundby B.
    Acad Radiol; 1996 Jul; 3(7):571-80. PubMed ID: 8796719
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers.
    Ros PR, Steinman RM, Torres GM, Burton SS, Panaccione JL, Rappaport DC, McGorray SP.
    AJR Am J Roentgenol; 1991 Oct; 157(4):761-7. PubMed ID: 1892032
    [Abstract] [Full Text] [Related]

  • 29. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 30. Observer reliability in CT and MRI of the abdomen/pelvis.
    Reker DM, Fletcher JW, Tantana S, Mahanta B, Vas W, Yoo R, Gresick RJ, Romeis JC, DuMontier CC, Heiberg E.
    Magn Reson Imaging; 1990 Mar; 8(5):577-82. PubMed ID: 2082127
    [Abstract] [Full Text] [Related]

  • 31. Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system.
    Gutierrez JE, Rosenberg M, Duhaney M, Simon JA, Brueggenwerth G, Agris JM, Knopp EA.
    J Magn Reson Imaging; 2015 Mar; 41(3):788-96. PubMed ID: 24578298
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B, Laniado M, Saini S.
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [Abstract] [Full Text] [Related]

  • 36. The safety and efficacy of neuroimaging with gadoversetamide injection in pediatric patients.
    Lowe LH, Kearns GL, Wible JH.
    Curr Med Res Opin; 2006 Dec; 22(12):2515-24. PubMed ID: 17166334
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intraluminal contrast agents for MR imaging of the abdomen and pelvis.
    Pels Rijcken TH, Davis MA, Ros PR.
    J Magn Reson Imaging; 1994 Dec; 4(3):291-300. PubMed ID: 8061424
    [Abstract] [Full Text] [Related]

  • 39. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN, Francis IR.
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.